Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2024), Lancet Child Adolesc Health, 8, 190 - 200
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City.
Journal article
Ziyatdinov A. et al, (2024), Nature, 626
Design, recruitment and baseline characteristics of the LENS trial.
Journal article
LENS Collaborative Group None., (2024), Diabetic medicine : a journal of the British Diabetic Association
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None. et al, (2024), Nat Commun, 15
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Journal article
EMPA-KIDNEY Collaborative Group None., (2024), The lancet. Diabetes & endocrinology, 12, 39 - 50
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Journal article
EMPA-KIDNEY Collaborative Group None., (2024), The lancet. Diabetes & endocrinology, 12, 51 - 60
Independent relevance of adiposity measures to coronary heart disease risk among 0.5 million adults in UK Biobank.
Journal article
Trichia E. et al, (2023), Int J Epidemiol, 52, 1836 - 1844
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2023), Lancet Diabetes Endocrinol, 11, 905 - 914
Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses.
Journal article
Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration None., (2023), Lancet Diabetes Endocrinol
Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease
Journal article
Mayne K. et al, (2023), Journal of the American Society of Nephrology
A deep catalog of protein-coding variation in 985,830 individuals.
Journal article
Sun KY. et al, (2023), bioRxiv
Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial.
Journal article
Wijesurendra RS. et al, (2023), Eur Heart J
Genotyping, sequencing and analysis of 140,000 adults from Mexico City.
Journal article
Ziyatdinov A. et al, (2023), Nature, 622, 784 - 793
Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model
Journal article
Wu R. et al, (2023), British Journal of General Practice
Educational and social inequalities and cause-specific mortality in Mexico City: a prospective study.
Journal article
Addey T. et al, (2023), Lancet Public Health, 8, e670 - e679
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
Journal article
Byrne RA. et al, (2023), Eur Heart J
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
Journal article
Byrne RA. et al, (2023), Eur J Cardiothorac Surg, 64
Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients.
Journal article
Staplin N. et al, (2023), Lancet, 401, 2041 - 2050
Rare coding variants in CHRNB2 reduce the likelihood of smoking.
Journal article
Rajagopal VM. et al, (2023), Nat Genet
Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP)
Journal article
HERRINGTON W. et al, (2023), Kidney International Reports